Sort
15,842 grants matching “pancreatic cancer”
Novel Human Cancer Cell Isolation System
$306,270James R. Eshleman · Johns Hopkins University · R01 · FY2010 · CA
Mechanistic Studies on New Platinum Clinical Agents
$306,250Virginia Commonwealth University · R01 · FY2003 · CA
PR55-alpha controlled PP2A in the regulation of the Hippo/YAP pathway
$306,167Ying Yan · University Of Nebraska Medical Center · R01 · FY2021 · GM
Control of the cell cycle by mRNA degradation
$306,150Mark E Schmitt · Upstate Medical University · R01 · FY2008 · GM
Mechanistic dissection and inhibitor targeting of autophagy in RAS driven cancers
$306,070Kirsten L Bryant · Univ Of North Carolina Chapel Hill · R37 · FY2024 · CA
Disrupting Protein-Protein Interactions With Bis-peptides
$306,000Christian E Schafmeister · Temple Univ Of The Commonwealth · R01 · FY2014 · GM
Chromatin targeting and transcriptional control by the histone variant H2A.Z
$305,987Roger Bancroft Deal · Emory University · R01 · FY2019 · GM
Next Generation Oncolytic Adenovirus for Advanced Pancreatic Cancer Treatment
$305,938Masato Yamamoto · University Of Minnesota · R01 · FY2014 · CA
Prevention of Tumor Progression by a Novel Approach
$305,938Fazlul H. Sarkar · Wayne State University · R01 · FY2014 · CA
Conformational based design and development of antitumor agents
$305,938Shelli R McAlpine · San Diego State University · R01 · FY2011 · CA
FoxM1: A molecular target in pancreatic cancer
$305,938Fazlul H. Sarkar · Wayne State University · R01 · FY2012 · CA
CCR2 BLOCKADE IN HUMAN PANCREATIC CANCER
$305,938David C Linehan · Washington University · R01 · FY2014 · CA
FoxM1: A molecular target in pancreatic cancer
$305,938Fazlul H. Sarkar · Wayne State University · R01 · FY2011 · CA
Molecular Analysis of Ras Oncogene Activated Gene Expres
$305,921Ohio State University · R01 · FY2002 · CA
Treatment of Hypoxia Resistance in Pancreatic Cancer -Lab
$305,909Garth Powis · Translational Genomics Research Inst · P01 · FY2007 · CA
Aurora Kinases as Therapeutic Targets in Pancreatic Cancer
$305,898Daniel D Von Hoff · Translational Genomics Research Inst · R01 · FY2007 · CA
Novel Single Domain Antibodies with Multivalency and Multispecificity
$305,832Rihe Liu · Univ Of North Carolina Chapel Hill · R01 · FY2012 · CA
Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis
$305,795Surinder Kumar Batra · University Of Nebraska Medical Center · P01 · FY2019 · CA
Analysis of Patient Tumor Responses to Apo2L/TRAIL
$305,795Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2009 · CA
Mechanism and role of DLC-1 tumor suppressor loss in lung cancer
$305,763Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA
Mechanism and role of DLC-1 tumor suppressor loss in lung cancer
$305,763Channing J Der · Univ Of North Carolina Chapel Hill · R01 · FY2010 · CA
The Role of Myc in ChREBP-dependent, Glucose-stimulated Gene Expression
$305,747Donald K Scott · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · DK
Novel Single Domain Antibodies with Multivalency and Multispecificity
$305,715Rihe Liu · Univ Of North Carolina Chapel Hill · R01 · FY2015 · CA
SURGICAL STUDIES OF PANCREATIC STEM CELLS
$305,696Johns Hopkins University · R01 · FY2003 · DK
Novel Single Domain Antibodies with Multivalency and Multispecificity
$305,673Rihe Liu · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA